|
Albany Molecular Research, doing business as AMRI, pushes drug development efforts along from start to finish. The company provides contract research and manufacturing services to pharmaceutical and biotechnology firms. The company's services run the gamut -- from compound screening and other drug discovery services to the contract manufacturing of drugs and drug ingredients for clinical trials and commercial sale. In addition to its work for other drug companies, AMRI conducts some of its own research, with the goal of licensing its compounds to other firms for further development. The company has R&D locations and manufacturing plants in North America, Europe, and Asia.
|
| | | Contact Information | |
Address: |
21 Corporate Cir.
Albany, NY 12212-5098
| | Phone: | 518-464-0279 | | Fax: | 518-464-0289 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 229.30 M | | Revenue Growth (1 yr): | 19.10% | | Employees (2008): | 1,357 | | Employee Growth (1 yr): | 10.70% |
|
|
Key People
| | • |
Chairman, President, and CEO:
Thomas E. D'Ambra
| | • |
SVP Administration, CFO, and Treasurer:
Mark T. Frost
| | • |
SVP Sales, Marketing, and Business Development:
W. Steven (Steve) Jennings
|
|
|
